Johnson & Johnson (JNJ) → Stock, financial statements

Johnson & Johnson: stocks, financial statements

Dividends News

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

  • JNJ Ticker
  • 🇩🇪 XETRA, 🇩🇪 F, 🇺🇸 NYSE Exchange
  • 135,100 Employees
129 rated

Financial statements — Johnson & Johnson

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
21 ← 17 2021 2019 2018 2017 2017
Total Revenue
83B 82B 82B 76B 72B
Cost Of Revenue
28B 28B 27B 25B 22B
Gross Profit
54B 55B 54B 51B 50B
Research and Development
12B 11B 11B 11B 9.1B
Selling General and Admin
22B 22B 23B 21B 20B
Operating Expense
63B 61B 60B 57B 51B
Operating Income
20B 21B 21B 19B 21B
Other Income Expense Net
0 0 0 0 0
20B 21B 21B 19B 21B
Interest Income
90M -39M 390M 550M 360M
Pretax Income
16B 17B 18B 18B 20B
Income Tax
1.8B 2.2B 2.7B 16B 3.3B
Minority Interest
0 0 0 0 0
Net Income
15B 15B 15B 1.3B 17B
Net Income Basic
15B 15B 15B 1.3B 17B
21 ← 17 2021 2019 2018 2017 2017
Current cash
25B 19B 20B 18B 42B
Short term investments
3.1B 2.4B 2.7B 2.5B 3.3B
14B 14B 14B 13B 12B
9.3B 9B 8.6B 8.8B 8.1B
Other current assets
3.1B 2.4B 2.7B 2.5B 3.3B
Current assets
51B 45B 46B 43B 65B
Long term investments
120B 110B 110B 110B 76B
Property plant equipment
19B 18B 17B 17B 16B
36B 34B 30B 32B 23B
Intangible assets
53B 48B 48B 53B 27B
Other assets
5.1B 4.5B 3.4B 4.2B 3.2B
Total assets
170B 160B 150B 160B 140B
Accounts payable
9.5B 8.5B 7.5B 7.3B 6.9B
Current long term debt
2.6B 1.2B 2.8B 3.9B 4.7B
Other current liabilities
30B 26B 21B 19B 15B
Total current liabilities
42B 36B 31B 31B 26B
Long term debt
33B 26B 28B 31B 22B
Other liabilities
29B 30B 27B 28B 19B
Minority Interest
0 0 0 0 0
Total Liabilities
110B 98B 93B 97B 71B
Common stock
2.6B 2.6B 2.7B 2.7B 2.7B
Retained earning
110B 110B 110B 100B 110B
Treasury stock
-38B -38B -34B -32B -28B
Capital surplus
Shareholder equity
63B 59B 60B 60B 70B
Net tangible assets
-27B -22B -18B -25B 21B
21 ← 17 2021 2019 2018 2017 2017
Net Income
15B 15B 15B 1.3B 17B
7.2B 7B 6.9B 5.6B 3.8B
Changes in receivables
-910M 380M 610M 1.8B 970M
Changes in inventories
320M 420M -170M 620M 91M
Cash change
5.9B -400M 1.4B -24B 3.5B
Cash flow
24B 23B 22B 21B 19B
Capital expenditures
-3.3B -3.5B -3.7B -3.3B -3.2B
Investing activity other
Total investing cash flows
-21B -6.2B -3.2B -15B -4.8B
Dividends paid
Net borrowings
6.9B 6B 8.1B 14B -18B
Other financing cash flows
Cash flow financing
-6.1B -18B -19B -7.7B -8.6B
Exchange rate effect